Palbociclib Hydrochloride (20:37), sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. Reference standards of Palbociclib Hydrochloride (20:37) API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Palbociclib Hydrochloride (20:37) - API Standards [catalogue_number] => PA 16 4130000 [category_ids] => ,75,76,78,70,82, [chemical_name] => [weight] => 20(447.54) + 37(36.46) [form] => 20(C24H29N7O2) . 37(HCl) [cas] => 571189-11-2 [pslug] => 571189-11-2-palbociclib-hydrochloride-20-37-api-standards-pa164130000 [latest_product] => 0 [linkproducts] => 1 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 16 4130000
CAS :
Molecular Formula : 20(C24H29N7O2) . 37(HCl)
Molecular Weight : 20(447.54) + 37(36.46)
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....